AbbVie Inc.'s Q1 earnings highlight an 8.4% revenue boost, driven by Skyrizi & Rinvoq. Click for ABBV's market expansion, ...

Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in ...

AbbVie raised its 2025 profit forecast on Friday after strong sales of its newer immunology drugs Skyrizi and Rinvoq helped ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...

A new study has uncovered another benefit of one of the country's most commonly prescribed medications for diabetes - joint ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.

The diabetes drug metformin provided overweight/obese patients with osteoarthritis (OA) of the knee with significantly ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...

New research suggests that lingering cell wall fragments from the Lyme disease bacterium, Borrelia burgdorferi, may be responsible for persistent symptoms long after antibiotic treatment.

II, a non-opioid treatment for knee osteoarthritis. Published in Osteoarthritis and Cartilage journal, the study reveals that ...